摘要
目的探讨奥氮平对淀粉样β蛋白25-35(Aβ25-35)诱导的PC12细胞凋亡的保护作用机制。方法以Aβ25-35诱导PC12细胞凋亡,采用MTT比色分析测定细胞存活率,应用Western blot检测Aβ25-35以及奥氮平对PC12细胞Bax、Caspase-3表达的影响,结果10^-14~10^-5mol/L的Aβ25-35减低PC12细胞存活率,50μmol/L及100μmol/I。奥氮平预处理24h可提高PC12细胞存活率,相同浓度Aβ25-35奥氮平预处理组与非处理组比较差异显著(P〈0.05);0.01、2、20μmol/L Aβ25-35处理的PC12细胞Bax表达增加,50μmol/L奥氮平预处理使0.01μmol/L和20μmol/L Aβ25-35诱导的PC12细胞Bax的表达减低(P〈O.05);2μmol/L及20μmol/L Aβ25-35处理的PC12细胞Caspase-3的表达增高,5μmol/L奥氮平预处理能抑制其表达升高,与非预处理比较差异显著(P〈O.05)。结论奥氮平可对抗Aβ25-35对PC12细胞的毒性作用,其机制可能与抑制Bax、Caspase-3的表达有关。
Objective To investigate the mechanism of the protective effects of olanzapine against apoptosis of PC12 cells induced by β- amyloid peptide 25--35 (Aβ25-35). Methods Based on the model of apoptosis of PC12 cells induced by Aβ25-35, cell viability was determined by MTT assay. The expressions of Bax, Caspase-3 of PC12 cells induced by Aβ25-35 and olanzapine were assessed by Western blot. Results 10^-14-10^-5mol/L Aβ25-35 lowered the cell viability of PC12 cells, 50μmol/L and 100μmol/L olanzapine pretreatment enhanced the cell viability of PC12 cells, and there was significant difference compared with olanzapine non-pretreated groups (P〈0. 05). 0. 01μmol/ L, 2μmol/L and 20μmol/L Aβ25-35 treatment up-regulated the Bax expression of PC12 cells, and 50μmol/L olanzapine pretreatment downregulated its expression, and difference was significant compared with olanzapine non-pretreated groups (P〈0. 05). 2μmol/L and 20μmol/ L Aβ25-35 treatment up-regulated the Caspase-3 expression of PC12 cells, 50μmol/L olanzapine pretreatment down-regulated its expression, the difference was significant compared with olanzapine non-pretreated groups (P〈0. 05). Conclusion Olanzapine can antagonize Aβ25-35 neurotoxicity to the PC12 cells. The mechanism of protection is likely related to a lowering in the Bax and Caspase-3 expression.
出处
《解放军医学杂志》
CAS
CSCD
北大核心
2006年第5期388-390,共3页
Medical Journal of Chinese People's Liberation Army